152 related articles for article (PubMed ID: 24634419)
21. Backbone and side-chain resonance assignments of the methyl-CpG-binding domain of MBD6 from Arabidopsis thaliana.
Iwakawa N; Mahana Y; Ono A; Ohki I; Walinda E; Morimoto D; Sugase K; Shirakawa M
Biomol NMR Assign; 2019 Apr; 13(1):59-62. PubMed ID: 30242623
[TBL] [Abstract][Full Text] [Related]
22. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2).
Valinluck V; Tsai HH; Rogstad DK; Burdzy A; Bird A; Sowers LC
Nucleic Acids Res; 2004; 32(14):4100-8. PubMed ID: 15302911
[TBL] [Abstract][Full Text] [Related]
23. A common ancestry for BAP1 and Uch37 regulators.
Sanchez-Pulido L; Kong L; Ponting CP
Bioinformatics; 2012 Aug; 28(15):1953-6. PubMed ID: 22645167
[TBL] [Abstract][Full Text] [Related]
24. Preferential binding of the methyl-CpG binding domain protein 2 at methylated transcriptional start site regions.
Chatagnon A; Perriaud L; Nazaret N; Croze S; Benhattar J; Lachuer J; Dante R
Epigenetics; 2011 Nov; 6(11):1295-307. PubMed ID: 22048253
[TBL] [Abstract][Full Text] [Related]
25. Control of the DNA methylation system component MBD2 by protein arginine methylation.
Tan CP; Nakielny S
Mol Cell Biol; 2006 Oct; 26(19):7224-35. PubMed ID: 16980624
[TBL] [Abstract][Full Text] [Related]
26. Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias.
Nair SS; Coolen MW; Stirzaker C; Song JZ; Statham AL; Strbenac D; Robinson MD; Clark SJ
Epigenetics; 2011 Jan; 6(1):34-44. PubMed ID: 20818161
[TBL] [Abstract][Full Text] [Related]
27. Structure-specific binding of MeCP2 to four-way junction DNA through its methyl CpG-binding domain.
Galvão TC; Thomas JO
Nucleic Acids Res; 2005; 33(20):6603-9. PubMed ID: 16314321
[TBL] [Abstract][Full Text] [Related]
28. Polycomb-like proteins link the PRC2 complex to CpG islands.
Li H; Liefke R; Jiang J; Kurland JV; Tian W; Deng P; Zhang W; He Q; Patel DJ; Bulyk ML; Shi Y; Wang Z
Nature; 2017 Sep; 549(7671):287-291. PubMed ID: 28869966
[TBL] [Abstract][Full Text] [Related]
29. Methyl-CpG-binding domain proteins: readers of the epigenome.
Du Q; Luu PL; Stirzaker C; Clark SJ
Epigenomics; 2015; 7(6):1051-73. PubMed ID: 25927341
[TBL] [Abstract][Full Text] [Related]
30. A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer.
Lopez-Serra L; Ballestar E; Fraga MF; Alaminos M; Setien F; Esteller M
Cancer Res; 2006 Sep; 66(17):8342-6. PubMed ID: 16951140
[TBL] [Abstract][Full Text] [Related]
31. A bidentate Polycomb Repressive-Deubiquitinase complex is required for efficient activity on nucleosomes.
Foglizzo M; Middleton AJ; Burgess AE; Crowther JM; Dobson RCJ; Murphy JM; Day CL; Mace PD
Nat Commun; 2018 Sep; 9(1):3932. PubMed ID: 30258054
[TBL] [Abstract][Full Text] [Related]
32. Methyl CpG-binding proteins and transcriptional repression.
Wade PA
Bioessays; 2001 Dec; 23(12):1131-7. PubMed ID: 11746232
[TBL] [Abstract][Full Text] [Related]
33. Methyl CpG binding proteins: coupling chromatin architecture to gene regulation.
Wade PA
Oncogene; 2001 May; 20(24):3166-73. PubMed ID: 11420733
[TBL] [Abstract][Full Text] [Related]
34. The solution structure of the domain from MeCP2 that binds to methylated DNA.
Wakefield RI; Smith BO; Nan X; Free A; Soteriou A; Uhrin D; Bird AP; Barlow PN
J Mol Biol; 1999 Sep; 291(5):1055-65. PubMed ID: 10518942
[TBL] [Abstract][Full Text] [Related]
35. Unmasking of epigenetically silenced candidate tumor suppressor genes by removal of methyl-CpG-binding domain proteins.
Lopez-Serra L; Ballestar E; Ropero S; Setien F; Billard LM; Fraga MF; Lopez-Nieva P; Alaminos M; Guerrero D; Dante R; Esteller M
Oncogene; 2008 Jun; 27(25):3556-66. PubMed ID: 18223687
[TBL] [Abstract][Full Text] [Related]
36. Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer.
Ballestar E; Paz MF; Valle L; Wei S; Fraga MF; Espada J; Cigudosa JC; Huang TH; Esteller M
EMBO J; 2003 Dec; 22(23):6335-45. PubMed ID: 14633992
[TBL] [Abstract][Full Text] [Related]
37. Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo.
Martinez E; Palhan VB; Tjernberg A; Lymar ES; Gamper AM; Kundu TK; Chait BT; Roeder RG
Mol Cell Biol; 2001 Oct; 21(20):6782-95. PubMed ID: 11564863
[TBL] [Abstract][Full Text] [Related]
38. Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1.
Ohki I; Shimotake N; Fujita N; Nakao M; Shirakawa M
EMBO J; 1999 Dec; 18(23):6653-61. PubMed ID: 10581239
[TBL] [Abstract][Full Text] [Related]
39. PHRF1 promotes genome integrity by modulating non-homologous end-joining.
Chang CF; Chu PC; Wu PY; Yu MY; Lee JY; Tsai MD; Chang MS
Cell Death Dis; 2015 Apr; 6(4):e1716. PubMed ID: 25855964
[TBL] [Abstract][Full Text] [Related]
40. MBD5 regulates iron metabolism via methylation-independent genomic targeting of Fth1 through KAT2A in mice.
Tao Y; Wu Q; Guo X; Zhang Z; Shen Y; Wang F
Br J Haematol; 2014 Jul; 166(2):279-91. PubMed ID: 24750026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
